|
| Exchange Disseminated Time 21/05/2018 11:19:20 | Nectar Lifesciences Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 28, 2018, inter alia, to consider and approve:
1. The Audited Financial Results for the Financial Year 2017-18, Financial Statements of the Company for the Financial Year 2017-18 and matters related thereto.
2. Recommendation of final dividend to the Members of the Company for Financial Year 2017-18.
Further, pursuant to Code of Conduct as per Regulation 9 of Securities & Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, the trading window of the Company shall stand closed from May 21, 2018 to May 30, 2018 (both days inclusive). |
|
|